U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C38H69NO14
Molecular Weight 763.9528
Optical Activity UNSPECIFIED
Defined Stereocenters 19 / 19
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 14-(R)-Hydroxyclarithromycin

SMILES

CO[C@]1(C)C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@H](OC(=O)[C@@H]2C)[C@@H](C)O)OC)O[C@@H](C)[C@@H]1O

InChI

InChIKey=BLPFDXNVUDZBII-KTDRUCRASA-N
InChI=1S/C38H69NO14/c1-18-16-37(9,48-14)32(53-35-28(42)25(39(11)12)15-19(2)49-35)21(4)29(51-26-17-36(8,47-13)31(44)24(7)50-26)22(5)34(45)52-33(23(6)40)38(10,46)30(43)20(3)27(18)41/h18-26,28-33,35,40,42-44,46H,15-17H2,1-14H3/t18-,19-,20+,21+,22-,23-,24+,25+,26+,28-,29+,30-,31+,32-,33-,35+,36-,37-,38+/m1/s1

HIDE SMILES / InChI

Molecular Formula C38H69NO14
Molecular Weight 763.9528
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 19 / 19
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 20:30:37 GMT 2025
Edited
by admin
on Wed Apr 02 20:30:37 GMT 2025
Record UNII
QS9JUX3AKY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
14-(R)-Hydroxyclarithromycin
Common Name English
(14R)-14-Hydroxyclarithromycin
Preferred Name English
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-12,13-dihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetra hydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexa
Systematic Name English
Erythromycin, 14-hydroxy-6-O-methyl-, (14R)-
Common Name English
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dion
Systematic Name English
Code System Code Type Description
FDA UNII
QS9JUX3AKY
Created by admin on Wed Apr 02 20:30:37 GMT 2025 , Edited by admin on Wed Apr 02 20:30:37 GMT 2025
PRIMARY
PUBCHEM
13921565
Created by admin on Wed Apr 02 20:30:37 GMT 2025 , Edited by admin on Wed Apr 02 20:30:37 GMT 2025
PRIMARY
CAS
116836-41-0
Created by admin on Wed Apr 02 20:30:37 GMT 2025 , Edited by admin on Wed Apr 02 20:30:37 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
Name Property Type Amount Referenced Substance Defining Parameters References
MIC BIOLOGICAL PATHOGEN: S. PYOGENES, S. PNEUMONIAE, H. PYLORI

SUSCEPTIBILITY: RESISTANT

Biological Half-life PHARMACOKINETIC 14-OH-CLARITHROMYCIN

MIC BIOLOGICAL PATHOGEN: S. AUREUS

SUSCEPTIBILITY: RESISTANT

MIC BIOLOGICAL PATHOGEN: H. INFLUENZAE

SUSCEPTIBILITY: SUSCEPTIBLE

MIC BIOLOGICAL SUSCEPTIBILITY: SUSCEPTIBLE

PATHOGEN: S. PYOGENES, S. PNEUMONIAE, H. PYLORI

MIC BIOLOGICAL SUSCEPTIBILITY: INTERMEDIATE

PATHOGEN: S. AUREUS

MIC BIOLOGICAL PATHOGEN: H. INFLUENZAE

SUSCEPTIBILITY: INTERMEDIATE

Biological Half-life PHARMACOKINETIC
MIC BIOLOGICAL PATHOGEN: S. AUREUS

SUSCEPTIBILITY: SUSCEPTIBLE

MIC BIOLOGICAL PATHOGEN: S. PYOGENES, S. PNEUMONIAE

SUSCEPTIBILITY: INTERMEDIATE

MIC BIOLOGICAL SUSCEPTIBILITY: RESISTANT

PATHOGEN: H. INFLUENZAE

Tmax PHARMACOKINETIC FORMULATION: IMMEDIATE RELEASE

Tmax PHARMACOKINETIC FORMULATION: EXTENDED RELEASE

ORAL BIOAVAILABILITY PHARMACOKINETIC